This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Panarelli, M. Articles by Kenyon, C. J. Search for Related Content PubMed PubMed Citation Articles by Panarelli, M. Articles by Kenyon, C. J.

Glucocorticoid Receptor Polymorphism, Skin Vasoconstriction, and Other Metabolic Intermediate Phenotypes in Normal Human Subjects¹

Clinical Biochemistry, Royal Infirmary (M.P.), Edinburgh; Medical Research Council Blood Pressure Group, Western Infirmary (C.D.H., R.F., J.M.C.C., M.C.I., N.H.A.), Glasgow; and Molecular Medicine Centre, Western General Hospital (C.J.K.), Edinburgh, Scotland

Address all correspondence and requests for reprints to: Christopher J. Kenyon, Molecular Medicine Center, Western General Hospital, Edinburgh, EH4 2XU, United Kingdom. E-mail: cjk{at}srv0.med.ed.ac.uk

Genetic variation of the glucocorticoid receptor (GR) locus is associated with differences in blood pressure. To define the intermediate phenotypes associated with this variation, we investigated the biochemical and clinical significance of a BclI restriction fragment length polymorphism of the GR locus in 64 normal male volunteers. Blood samples were genotyped as either AA (homozygous large allele; n = 6), Aa (heterozygous; n = 51), or aa (homozygous small allele, n = 7). Four primary glucocorticoid variables were measured including GR binding characteristics and glucocorticoid-sensitive lysozyme release of leukocytes in vitro and the blanching response of forearm skin to budesonide. A large number of secondary variables (urinary and plasma steroid measurements, blood pressure and indices of body fat metabolism, and routine biochemical and hematological measurements) were also considered. In vivo sensitivity to budesonide was greater in AA than aa individuals (mean ± SE EC₅₀ values: 13 ± 5 and 42 ± 10 ng; P < 0.01). In contrast, leukocytes of AA subjects tended to have lower affinity and reduced sensitivity for dexamethasone, although these effects were not statistically significant. Based on urinary steroid measurements, 11ß-hydroxysteroid dehydrogenase activity [ratio of tetrahydrocortisol (THF) to tetrahydrocortisone (THE) metabolites] was not affected by genotype. The relative activities of 5- and 5ß-reductase activity (allo-THF/THF + THE) appeared lower in AA than aa subjects (0.22 ± 0.04 cf. 0.33 ± 0.06; P < 0.005) but were not judged to be significantly different when corrected for multiple comparisons. Single and multivariate analyses were carried out to determine which variables influence GR binding characteristics and glucocorticoid responsiveness and to see whether cardiovascular risk factors (blood pressure and body fat) were influenced by glucocorticoid-dependent functions. Only 15–20% of the variations in the dissociation constant (K_d) and maximum binding capacity (B_max) were influenced by other variables; plasma cholesterol was the most important for affinity and plasma sodium concentration for binding capacity. Multivariate analysis showed that several factors including GR genotype and urinary cortisol account for 10% of the variation of in vivo responses to glucocorticoid hormones; plasma calcium concentration was the only variable that contributed to in vitro sensitivity of leukocytes to dexamethasone. Glucocorticoid-dependent responses were of negligible importance in determining blood pressure or percentage body fat within the narrow physiological ranges of the present study. We conclude that GR genotype affects steroid sensitivity in a tissue-specific manner because of altered GR function or possibly because of linkage to a locus that controls hormone access to the receptor by influencing steroid metabolism.

This article has been cited by other articles:

				Z. Michailidou, R. N. Carter, E. Marshall, H. G. Sutherland, D. G. Brownstein, E. Owen, K. Cockett, V. Kelly, L. Ramage, E. A. S. Al-Dujaili, et al. Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet FASEB J, November 1, 2008; 22(11): 3896 - 3907. [Abstract] [Full Text] [PDF]

				A. S. Tait, C. L. Butts, and E. M. Sternberg The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease J. Leukoc. Biol., October 1, 2008; 84(4): 924 - 931. [Abstract] [Full Text] [PDF]

				B Boyle, K Koranyi, A Patocs, I Liko, A Szappanos, R Bertalan, K Racz, and C Balazs Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy Br. J. Ophthalmol., January 1, 2008; 92(1): 131 - 134. [Abstract] [Full Text] [PDF]

				B. R Walker Glucocorticoids and Cardiovascular Disease Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559. [Abstract] [Full Text] [PDF]

				S. De Iudicibus, G. Stocco, S. Martelossi, I. Drigo, S. Norbedo, P. Lionetti, E. Pozzi, A. Barabino, G. Decorti, F. Bartoli, et al. Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease Gut, September 1, 2007; 56(9): 1319 - 1320. [Full Text] [PDF]

				A. Rautanen, J. G. Eriksson, J. Kere, S. Andersson, C. Osmond, P. Tienari, H. Sairanen, D. J. P. Barker, D. I. W. Phillips, T. Forsen, et al. Associations of Body Size at Birth with Late-Life Cortisol Concentrations and Glucose Tolerance Are Modified by Haplotypes of the Glucocorticoid Receptor Gene J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4544 - 4551. [Abstract] [Full Text] [PDF]

				K. N. Priftis, A. Papadimitriou, E. Gatsopoulou, P. K. Yiallouros, A. Fretzayas, and P. Nicolaidou The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children Eur. Respir. J., February 1, 2006; 27(2): 316 - 320. [Abstract] [Full Text] [PDF]

				R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984. [Abstract] [Full Text] [PDF]

				E B Lee, J Y Kim, Y J Lee, and Y W Song Glucocorticoid receptor polymorphisms in Korean patients with rheumatoid arthritis Ann Rheum Dis, March 1, 2005; 64(3): 503 - 504. [Full Text] [PDF]

				E. F. C. van Rossum, P. G. Voorhoeve, S. J. te Velde, J. W. Koper, H. A. Delemarre-van de Waal, H. C. G. Kemper, and S. W. J. Lamberts The ER22/23EK Polymorphism in the Glucocorticoid Receptor Gene Is Associated with a Beneficial Body Composition and Muscle Strength in Young Adults J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4004 - 4009. [Abstract] [Full Text] [PDF]

				S. Wust, E. F. C. van Rossum, I. S. Federenko, J. W. Koper, R. Kumsta, and D. H. Hellhammer Common Polymorphisms in the Glucocorticoid Receptor Gene Are Associated with Adrenocortical Responses to Psychosocial Stress J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 565 - 573. [Abstract] [Full Text] [PDF]

				A. A. Syed, J. A. E. Irving, C. P. F. Redfern, A. G. Hall, N. C. Unwin, M. White, R. S. Bhopal, K. G. M. M. Alberti, and J. U. Weaver Low Prevalence of the N363S Polymorphism of the Glucocorticoid Receptor in South Asians Living in the United Kingdom J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 232 - 235. [Abstract] [Full Text] [PDF]

				E. F.C. van Rossum and S. W.J. Lamberts Polymorphisms in the Glucocorticoid Receptor Gene and Their Associations with Metabolic Parameters and Body Composition Recent Prog. Horm. Res., January 1, 2004; 59(1): 333 - 357. [Abstract] [Full Text]

				J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393. [Abstract] [Full Text]

				S. Koyano, Y. Saito, M. Nagano, K. Maekawa, Y. Kikuchi, N. Murayama, T. Fujino, S. Ozawa, T. Nakajima, K. Matsumoto, et al. Functional Analysis of Three Genetic Polymorphisms in the Glucocorticoid Receptor Gene J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 110 - 116. [Abstract] [Full Text] [PDF]

				I. Fleury, P. Beaulieu, M. Primeau, D. Labuda, D. Sinnett, and M. Krajinovic Characterization of the BclI Polymorphism in the Glucocorticoid Receptor Gene Clin. Chem., September 1, 2003; 49(9): 1528 - 1531. [Full Text] [PDF]

				R. C. Andrews, O. Herlihy, D. E. W. Livingstone, R. Andrew, and B. R. Walker Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5587 - 5593. [Abstract] [Full Text] [PDF]

				C. D Byrne Programming other hormones that affect insulin: Type 2 diabetes Br. Med. Bull., November 1, 2001; 60(1): 153 - 171. [Abstract] [Full Text] [PDF]

				L Patel, J K Wales, M S Kibirige, A A Massarano, J M Couriel, P E Clayton, and G. RUSSELL Symptomatic adrenal insufficiency during inhaled corticosteroid treatment Arch. Dis. Child., October 1, 2001; 85(4): 330 - 334. [Abstract] [Full Text] [PDF]

				M. G. Dobson, C. P. F. Redfern, N. Unwin, and J. U. Weaver The N363S Polymorphism of the Glucocorticoid Receptor: Potential Contribution to Central Obesity in Men and Lack of Association with Other Risk Factors for Coronary Heart Disease and Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2270 - 2274. [Abstract] [Full Text]

				J. A. Whitworth, G. J. Mangos, and J. J. Kelly Cushing, Cortisol, and Cardiovascular Disease Hypertension, November 1, 2000; 36(5): 912 - 916. [Abstract] [Full Text] [PDF]

				M. Ebrecht, A. Buske-Kirschbaum, D. Hellhammer, S. Kern, N. Rohleder, B. Walker, and C. Kirschbaum Tissue Specificity of Glucocorticoid Sensitivity in Healthy Adults J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3733 - 3739. [Abstract] [Full Text]

				R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension Hypertension, December 1, 1999; 34(6): 1186 - 1192. [Abstract] [Full Text] [PDF]

				R. Fraser, M. C. Ingram, N. H. Anderson, C. Morrison, E. Davies, and J. M. C. Connell Cortisol Effects on Body Mass, Blood Pressure, and Cholesterol in the General Population Hypertension, June 1, 1999; 33(6): 1364 - 1368. [Abstract] [Full Text] [PDF]

				S. Takami, Z. Y. H. Wong, M. Stebbing, and S. B. Harrap Linkage analysis of glucocorticoid and beta 2-adrenergic receptor genes with blood pressure and body mass index Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1379 - H1384. [Abstract] [Full Text] [PDF]

				G. P. Chrousos and P. W. Gold A Healthy Body in a Healthy Mind--and Vice Versa--The Damaging Power of "Uncontrollable" Stress J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1842 - 1845. [Full Text]